Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies

Cancer

Volumn 91, Issue 12, 2001, Pages 2205-2213

  Cao, Thai M ^a   Kusnierz Glaz, Claus ^a   Valone, Frank ^a   Stockerl Goldstein, Keith E ^b   Hu, Wendy W ^a   Johnston, Laura ^a   Blume, Karl G ^a   Strober, Samuel ^a   Negrin, Robert S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dendreon   (United States)

Author keywords

Allogeneic transplantation; Density gradient; Graft versus host disease; Natural suppressor cells

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ANTIGEN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOTRANSPLANTATION; APHERESIS; ARTICLE; BLOOD DISEASE; CELL DENSITY; CLINICAL ARTICLE; DENSITY GRADIENT CENTRIFUGATION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOCYTE DEPLETION; MALE; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE SUBPOPULATION; WHOLE BODY RADIATION;

ADULT; ANTIGENS, CD34; CELL SEPARATION; CENTRIFUGATION, DENSITY GRADIENT; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0035876268     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010615)91:12<2205::AID-CNCR1250>3.0.CO;2-Q     Document Type: Article

References (38)

1. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
2. Allogeneic blood stem cell transplantation in advanced hematologic cancers
3. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de greffe de moelle
4. A prospective, randomised trial of peripheral blood stem cells (PBSC) or marrow (BM) for patients undergoing allogeneic transplantation for hematologic malignancies
5. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts
6. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: Effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies
7. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
8. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease
9. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease
10. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: Impact on blood progenitor cell transplantation
11. Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors
12. Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity
13. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma
14. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease
15. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies
16. Prediction of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients
17. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: Long-term follow-up
18. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation
19. Practical Bayesian guidelines for phase IIB clinical trials
20. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor
21. Nonparametric estimation from incomplete observations
22. Evaluation of survival data and two new rank order statistics arising in its consideration
23. Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation
24. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants
25. Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+ CD4- and not by CD8- CD4+ thymocytes
26. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans
27. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells
28. CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers
29. Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts
30. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions
31. Allogeneic transplantation of selected CD34+ cells from peripheral blood: Experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT
32. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors
33. Transplantation of allogeneic CD34+ blood cells
34. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: A prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism
35. Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation
36. Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse
37. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients